ID   PEO16
AC   CVCL_2688
SY   PE016
DR   CancerTools; 151676
DR   ECACC; 10032312
DR   Wikidata; Q54947166
DR   Ximbio; 151676
RX   PubMed=3167863;
RX   PubMed=25230021;
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Doubling time: 40 hours (PubMed=3167863); ~120 hours (ECACC=10032312).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ECACC; PubMed=25230021
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 13
ST   D16S539: 12
ST   D18S51: 12,19
ST   D19S433: 13,14.2
ST   D21S11: 30
ST   D2S1338: 20,23
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8
ST   D8S1179: 14,15
ST   FGA: 19,22
ST   Penta D: 13
ST   Penta E: 7
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C5228; Ovarian cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
RX   PubMed=3167863;
RA   Langdon S.P., Lawrie S.S., Hay F.G., Hawkes M.M., McDonald A.,
RA   Hayward I.P., Schol D.J., Hilgers J., Leonard R.C.F., Smyth J.F.;
RT   "Characterization and properties of nine human ovarian adenocarcinoma
RT   cell lines.";
RL   Cancer Res. 48:6166-6172(1988).
//
RX   PubMed=25230021; DOI=10.1371/journal.pone.0103988;
RA   Beaufort C.M., Helmijr J.C.A., Piskorz A.M., Hoogstraat M.,
RA   Ruigrok-Ritstier K., Besselink N., Murtaza M., van IJcken W.F.J.,
RA   Heine A.A.J., Smid M., Koudijs M.J., Brenton J.D., Berns E.M.J.J.,
RA   Helleman J.;
RT   "Ovarian cancer cell line panel (OCCP): clinical importance of in
RT   vitro morphological subtypes.";
RL   PLoS ONE 9:E103988-E103988(2014).
//